Source: Medical Device Network

Synapse BiomedicalInc: FDA approves Synapse's NeuRx DPS to treat patients with stable SCI

NeuRx DPS can be used to help patients 18 years and older to breathe without the support of a mechanical ventilator. The post FDA approves Synapse's NeuRx DPS to treat patients with stable SCI appeared first on Medical Device Network.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Anthony R. Ignagni's photo - President & CEO of Synapse BiomedicalInc

President & CEO

Anthony R. Ignagni

CEO Approval Rating

90/100